Navigation Links
CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
Date:5/17/2012

b>(HKSTPC) is a statutory body set up by the Hong Kong government. HKSTPC provides innovative and technology driven infrastructure and support facilities which include market focused clustered laboratory services enabling Hong Kong industries and services to be more competitive; it provides a full-service incubation programme for technology and design start-ups, and fosters partnerships and collaboration between industry and universities/applied research institutes through consulting, training and research programmes. HKSTPC offers advanced facilities and support services for high technology companies. For more information, see www.hkstp.org.

Ventac Partners is a dedicated life science consulting firm with offices in Europe, USA and Asia. The firm has a strong track record of founding new innovative companies, strategic and operational market and product analysis, intellectual property development, fund raising, licensing, M&A and strategy consulting. All partners are experienced executives from pharma, biotech and medtech companies, with extensive backgrounds in successfully starting, growing and expanding international life science companies. For more information, see www.ventac-partners.com.

Media Contacts:
Ventac Partners (Boston office)
Dr. Robert L. Buchanan, Partner
Tel: +1-617-418-1600
Email: rbuchanan@ventac-partners.com

Investor Contacts:
CASiGEN Pharma Ltd (Hong Kong)
Dr. Stephen Lee, Chief Executive Officer
Tel: +852 6650 6402
Email: slee@ventac-partners.com 

For more information about GIBH: 
Guangzhou Institute of Biomedicine and Health, Chinese
Academy of Sciences (Guangzhou)
Dr. Duanqing Pei, Director General
Tel: +86-20 32015300
Email:

SOURCE Ventac Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Johnson & Johnson (NYSE: JNJ ... third party to review requests made to the Janssen ... for compassionate use of its investigational medicines. This new ... a single Janssen investigational medicine and, if successful, will ... across Johnson & Johnson. In keeping with ...
(Date:5/6/2015)... , May 6, 2015  Zimmer Holdings, Inc. (NYSE and ... that it will be presenting at the Bank of America ... hotel in Las Vegas, Nevada on ... A live webcast of the presentation can be accessed ... webcast will be archived for replay following the conference. ...
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Radient Pharmaceuticals Corporation (OTCQX: RXPC.PK - News ... developer and marketer of cancer tests, today announces it ... in Taipei, Taiwan. Previously, Radient,s agreement with ... Radient,s flagship product Onko-Sure® cancer test in Taiwan.  Radient ...
... Dec. 21, 2011  Shareholders of Medco Health Solutions, Inc. (NYSE: ... Express Scripts. (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) ... vote present in person or by proxy at a special ... Merger dated July 20, 2011 by a margin of 99 ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 2Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 3Medco Shareholders Approve Merger With Express Scripts 2
(Date:5/6/2015)... New Standards for Excipient GMPs:, ... May 27, 2015 — 1:30 p.m. – 3:00 ... contain 70-90% excipients, which serve as taste-maskers, glidants, ... that facilitate the manufacturing process and improve chemical ... with a regulatory focus on preventing counterfeits and ...
(Date:5/6/2015)... Device Patent Law Changes:, Six Key Areas of Concern, ... p.m. EDT, http://www.fdanews.com/DevicePatentLaw , Every year, medical device ... that waste their time. , It doesn't have to ... if devicemakers better understand the trouble spots to watch out ... patent laws from all around the world. , Why not ...
(Date:5/6/2015)... May 07, 2015 With recent headlines about ... Hong Kong by 6 men from Southern China, it is ... be a real concern for them. This is especially true ... who may attract unwanted attention through the property they own, ... they look. Fortunately for those individuals, families and companies that ...
(Date:5/6/2015)... 2015 The dates have been selected ... Game Changers Summit 2015 , an Information & Technology ... Methodist Communications. Join the international gathering September 17-19 at ... communication leaders from around the globe will speak and ... throughout the developing world. , The theme of the ...
(Date:5/6/2015)... 06, 2015 With an estimated 300,000 ... to its potentially dangerous health effects, the Horizon Foundation ... BEAM (Breathe Easier with Asthma Management) – to improve ... being funded through a $500,000 foundation grant to the ... is implementing BEAM throughout the state. , “While asthma ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4
... Today,s ubiquitous MP3 players permit users to listen to crystal-clear ... marked improvement on the days of the Walkman. But according ... personal listening devices into a serious health hazard, with teenagers ... four teens is in danger of early hearing loss as ...
... Allergists, pulmonologists and general practitioners can learn the approaches ... and immune diseases at the 34th Annual Pulmonary & ... Jewish Health. The program, co-chaired by National Jewish professors ... MD, offers an opportunity to interact with the world,s ...
... single class of proteins and now scientists have identified ... those proteins critical to our health. A protein known ... from a team led by Gregory Tall, Ph.D., assistant professor ... Center. The work was published recently in Science Signaling ...
... -- While the holidays tend to translate into restaurant meals ... at home, eating out doesn,t have to be unhealthy, an ... Americans from consuming hundreds of extra calories. "The average ... meals outside of the home and fast-food restaurants are abundant," ...
... WASHINGTONDecember 27, 2011Research!America,s new national voter education initiative, ... and Republican Presidential candidate Newt Gingrich on important ... highlights: both Obama and Gingrich agree that ... part of the solution to rising health care ...
... Maryland, December, 27, 2011 Neuralstem, Inc. (NYSE Amex: CUR) ... and Drug Administration to advance to Phase Ib in ... compound, NSI-189, for the treatment of major depressive disorder ... of the drug in depressed patients. NSI-189 is a ...
Cached Medicine News:Health News:Turn down the iPod to save your hearing 2Health News:Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets 2Health News:Eating Out Doesn't Have to Mean Excess Calories 2Health News:President Obama and leading GOP presidential candidate support health research 2Health News:President Obama and leading GOP presidential candidate support health research 3Health News:Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib 2Health News:Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib 3
... duet Signature Series multipurpose gamma ... FDG imaging applications. The system uniquely combines ... the features and flexibility of modern day ... unit.,The e.cam duet maximizes camera ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
... AXIOM Artis FA is ... C-arm system whose flexible ... for vascular and non-vascular ... provides complete ergonomic system ...
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
Medicine Products: